<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: exenatide</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Diabetes drug tested in Parkinson's disease patients</title>
   	 <description>Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the progression of the disease.</description>
     <link>http://medicalxpress.com/news/2013-05-diabetes-drug-parkinson-disease-patients.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Mon, 20 May 2013 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news288269009</guid>
	 
</item>
<item>
     <title>Diabetes drug may offer 'modest' weight loss for very obese teens</title>
   	 <description>(HealthDay)—The drug Byetta, approved for adults with type 2 diabetes, appears to help severely obese teens lose some weight, a small study found.</description>
     <link>http://medicalxpress.com/news/2013-02-diabetes-drug-modest-weight-loss.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Tue, 05 Feb 2013 13:00:40 EST</pubDate>
	 <guid isPermaLink="false">news279291613</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-diabetesdrug.jpg" width="90" height="90" />
</item>
<item>
     <title>Study suggests glucagon-like peptide-1 receptor agonists related to adolescent weight loss</title>
   	 <description>Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a report published Online First by JAMA Pediatrics.</description>
     <link>http://medicalxpress.com/news/2013-02-glucagon-like-peptide-receptor-agonists-adolescent.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Mon, 04 Feb 2013 16:00:12 EST</pubDate>
	 <guid isPermaLink="false">news279197910</guid>
	 
</item>
<item>
     <title>Head-to-head trial of two diabetes drugs yields mixed results</title>
   	 <description>A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results.</description>
     <link>http://medicalxpress.com/news/2012-11-head-to-head-trial-diabetes-drugs-yields.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 06 Nov 2012 20:00:02 EST</pubDate>
	 <guid isPermaLink="false">news271438319</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/headtoheadtr.jpg" width="90" height="90" />
</item>
<item>
     <title>Everyday drugs could combat dementia, according to major study</title>
   	 <description>(Medical Xpress)—Medications used to treat hypertension, diabetes and skin conditions could be doubling as treatments for Alzheimer's within 10 years according to researchers. A groundbreaking new study funded by Alzheimer's Society and led by King's College London identifies four existing drugs and one drug class which could reduce risk or slow down symptoms of the disease. The study, published in Nature Reviews Drug Discovery today forms a key part of ongoing drug discovery work which aims to accelerate the search for a cure and drugs for dementia by looking at existing treatments.</description>
     <link>http://medicalxpress.com/news/2012-11-everyday-drugs-combat-dementia-major.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 01 Nov 2012 06:44:42 EST</pubDate>
	 <guid isPermaLink="false">news270970967</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/60-clipboard-1.jpg" width="90" height="90" />
</item>
<item>
     <title>Drugs from lizard saliva reduces the cravings for food</title>
   	 <description>A drug made from the saliva of the Gila monster lizard is effective in reducing the craving for food. Researchers at the Sahlgrenska Academy, University of Gothenburg, have tested the drug on rats, who after treatment ceased their cravings for both food and chocolate.</description>
     <link>http://medicalxpress.com/news/2012-05-drugs-lizard-saliva-cravings-food.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 15 May 2012 15:19:46 EST</pubDate>
	 <guid isPermaLink="false">news256313978</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/drugsfromliz.jpg" width="90" height="90" />
</item>
<item>
     <title>Exenatide (Byetta) has rapid, powerful anti-inflammatory effect, study shows</title>
   	 <description>Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.</description>
     <link>http://medicalxpress.com/news/2011-11-exenatide-byetta-rapid-powerful-anti-inflammatory.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Wed, 02 Nov 2011 11:35:51 EST</pubDate>
	 <guid isPermaLink="false">news239452542</guid>
	 
</item>
<item>
     <title>Study suggests possible link between two Type 2 diabetes drugs and pancreatic cancer</title>
   	 <description>Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according to a new UCLA study.</description>
     <link>http://medicalxpress.com/news/2011-09-link-diabetes-drugs-pancreatic-cancer.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 16 Sep 2011 16:52:43 EST</pubDate>
	 <guid isPermaLink="false">news235410714</guid>
	 
</item>


</channel>
</rss>
